Tyra Biosciences, Inc.

TYRA

Tyra Biosciences, Inc.

TYRA

Insider Sentiment (TTM):

Last Purchase:2025-06-16Last Sale:2026-03-25Shares Purchased (TTM):0Shares Sold (TTM):365,194

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:64,676,168Shares Outstanding:61,746,050Institutional Ownership Pct.:104.75%

Earnings Market Reaction:

Filing Date:2026-08-04Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	74	85	77	62	98	101	92	104	99	254	58	216
Marketable Securities	280	299	179	213	198	218	249	256	274	128	145	-
Prepaid Expense And Other Assets Current	13	11	9	6	6	6	6	5	5	8	8	9
Assets Current	367	395	265	281	302	325	347	366	379	391	212	225
Restricted Cash Noncurrent	1	1	1	1	1	1	1	1	1	1	1	1
Property Plant And Equipment Net	1	1	1	1	1	2	2	2	2	2	2	1
Other Assets Noncurrent	9	10	9	13	11	10	7	6	5	5	5	5
Assets	383	412	283	302	321	343	364	381	392	405	226	238
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	2	4	1	2	2	3	1	1	2	3	5	2
Operating Lease Liability Current	1	0	0	0	0	0	0	0	0	0	0	0
Other Accrued Liabilities Current	22	15	16	13	11	11	14	11	8	5	10	8
Liabilities Current	25	19	18	16	14	14	15	12	10	9	15	10
Operating Lease Liability Noncurrent	5	5	5	5	6	6	6	6	6	6	6	6
Other Liabilities Noncurrent	-	-	0	0	0	0	0	0	0	0	0	0
Liabilities	30	24	23	21	19	20	20	18	16	15	22	16
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	810	798	630	617	609	602	594	586	578	573	369	364
Accumulated Other Comprehensive Income Loss Net Of…	-1	0	0	0	0	1	1	2	-0	-0	0	-
Retained Earnings Accumulated Deficit	-456	-411	-371	-337	-308	-279	-251	-226	-202	-183	-165	-142
Stockholders Equity	354	388	259	281	302	324	343	362	376	390	204	222
Liabilities And Stockholders Equity	383	412	283	302	321	343	364	381	392	405	226	238
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	50	50	50	50	50	50	50	50	50	50	50	50
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	500	500	500	500	500	500	500	500	500	500	500	500
Common Stock Shares Issued	60	59	54	53	53	53	51	53	53	53	43	43
Shares Outstanding	60	59	54	53	53	53	51	53	53	52	43	43

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-26.39%	-15.39%	-11.91%	-	-	-	-	-	-	-	-	-
2025	-9.63%	-9.63%	9.83%	18.22%	27.66%	48.04%	52.23%	75.17%	104.93%	11.59%	15.59%	-0.15%
2024	-8.67%	-9.97%	13.12%	16.72%	19.69%	12.46%	-8.57%	-17.96%	-7.41%	-7.66%	3.42%	7.97%
2023	-	-	-	-0.73%	-8.87%	-27.00%	-4.52%	13.90%	6.50%	-7.52%	7.76%	22.86%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	14.91	20.49	14.67	17.71	21.94	22.78	23.81	29.55	36.46	44.83	13.80	22.14
Quick Ratio	14.38	19.91	14.15	17.31	21.52	22.39	23.40	29.11	36.00	43.88	13.27	21.25
Working Capital	342.35M	375.36M	247.36M	265.34M	288.39M	310.32M	332.87M	353.24M	368.19M	382.06M	196.34M	214.48M
Leverage & Debt
Debt to Equity	0.08	0.06	0.09	0.08	0.06	0.06	0.06	0.05	0.04	0.04	0.11	0.07
Debt Ratio	0.08	0.06	0.08	0.07	0.06	0.06	0.06	0.05	0.04	0.04	0.10	0.07
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-2.25	-2.12	-2.01	-1.87	-1.78	-1.63	-1.51	-1.42	-1.38	-1.44	-1.62	-1.38
Free Cash Flow Per Share TTM	-1.56	-1.66	-1.60	-1.10	-1.03	-1.24	-1.23	-1.10	-1.10	-1.21	-1.19	-1.14
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	40.38%	35.95%	38.70%	33.37%	30.86%	27.82%	25.09%	41.46%	59.97%	44.04%	24.96%	-4.64%
EPS Growth (1Y)	26.68%	30.65%	33.15%	31.59%	28.92%	12.51%	-6.64%	3.00%	16.13%	16.92%	22.56%	-6.58%
Valuation Metrics
P/E TTM	-14.19	-18.04	-13.06	-7.47	-5.38	-5.72	-9.20	-16.53	-11.60	-11.35	-8.56	-9.97
P/B TTM	5.96	6.10	6.05	2.98	1.89	1.71	2.32	3.82	2.49	2.20	2.90	2.66
Market Cap	2.11B	2.36B	1.57B	834.79M	569.90M	551.83M	795.33M	1.38B	938.11M	856.55M	591.46M	590.30M
Enterprise Value	2.03B	2.28B	1.49B	771.84M	470.41M	450.11M	702.36M	1.28B	837.62M	601.19M	532.46M	373.65M
Calculated Values
Free Cash Flow TTM	-102.76M	-102.47M	-95.28M	-65.73M	-61.26M	-73.75M	-70.44M	-64.98M	-64.26M	-63.19M	-50.91M	-48.78M
Net Debt	-74.84M	-85.96M	-78.39M	-62.95M	-99.49M	-101.72M	-92.97M	-104.89M	-100.49M	-255.37M	-59.01M	-216.65M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-03-25Sale

Owner: Kaplan, Gilla

Title: -

Shares: 14,295

Price/Share: $36.97

Value: $528,486.15

Shares Owned: 28,231

Relationship: Director

Ownership: Direct

2026-02-12Sale

Owner: Bensen, Daniel

Title: Chief Discovery Officer

Shares: 8,000

Price/Share: $32.44

Value: $259,520.00

Shares Owned: 146,981

Relationship: Officer

Ownership: Direct

2026-01-12Sale

Owner: Bensen, Daniel

Title: Chief Discovery Officer

Shares: 8,000

Price/Share: $28.76

Value: $230,080.00

Shares Owned: 154,981

Relationship: Officer

Ownership: Direct

2025-12-19Sale

Owner: More, Robert J

Title: -

Shares: 10,000

Price/Share: $25.00

Value: $250,000.00

Shares Owned: 3,823,425

Relationship: Director

Ownership: Indirect

2025-12-12Sale

Owner: Bensen, Daniel

Title: Chief Discovery Officer

Shares: 8,000

Price/Share: $22.64

Value: $181,120.00

Shares Owned: 162,981

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-03-25	Kaplan, Gilla	Director	-	Direct	Sale	14,295	36.97	$528,486.15	28,231	4
2026-02-12	Bensen, Daniel	Officer	Chief Discovery Officer	Direct	Sale	8,000	32.44	$259,520.00	146,981	4
2026-01-12	Bensen, Daniel	Officer	Chief Discovery Officer	Direct	Sale	8,000	28.76	$230,080.00	154,981	4
2025-12-19	More, Robert J	Director	-	Indirect	Sale	10,000	25.00	$250,000.00	3,823,425	4
2025-12-12	Bensen, Daniel	Officer	Chief Discovery Officer	Direct	Sale	8,000	22.64	$181,120.00	162,981	4
2025-11-21	More, Robert J	Director	-	Indirect	Sale	246,871	20.25	$4,999,137.75	3,833,425	4
2025-11-19	Bensen, Daniel	Officer	Chief Operating Officer	Direct	Sale	49,956	16.32	$815,281.92	170,981	4
2025-11-17	Bensen, Daniel	Officer	Chief Operating Officer	Direct	Sale	20,072	16.59	$332,994.48	296,570	4
2025-06-18	Kaplan, Gilla	Director	-	Direct	Sale	9,568	9.78	$93,575.04	28,231	4
2025-06-16	Ra, Capital Management, L…	Director	-	Indirect	Purchase	11,813	10.13	$119,665.69	10,259,291	4
2025-06-16	Kaplan, Gilla	Director	-	Direct	Sale	6,814	10.38	$70,729.32	37,809	4
2025-06-09	Ra, Capital Healthcare Fu…	Director	-	Indirect	Purchase	186,850	10.19	$1,904,001.50	10,096,004	4
2025-06-05	Kolchinsky, Peter, Ra Cap…	Director,TenPercentOwner	-	Indirect	Purchase	213,334	10.04	$2,141,873.36	9,909,154	4
2025-02-05	Kjellson, Nina S	Director	-	Indirect	Sale	5,401	13.76	$74,317.76	443,885	4
2025-01-23	Kjellson, Nina S	Director	-	Indirect	Sale	4,825	16.26	$78,454.50	3,702,595	4
2025-01-21	Kjellson, Nina S	Director	-	Indirect	Sale	3,993	16.36	$65,325.48	3,707,420	4
2024-11-25	Kjellson, Nina S	Director	-	Indirect	Sale	5,272	16.84	$88,780.48	448,692	4
2024-11-08	Ra, Capital Healthcare Fu…	Director,TenPercentOwner	-	Indirect	Purchase	1,220,681	16.25	$19,836,066.25	8,697,956	4
2024-11-07	Kjellson, Nina S	Director	-	Indirect	Sale	22,091	17.32	$382,616.12	449,258	4
2024-11-05	Kjellson, Nina S	Director	-	Indirect	Sale	10,493	16.77	$175,967.61	457,264	4
2024-11-01	Kjellson, Nina S	Director	-	Indirect	Sale	27,493	16.85	$463,257.05	458,506	4
2024-10-30	Fuhrman, Alan	Officer	Chief Financial Officer	Direct	Purchase	9,500	16.00	$152,000.00	12,849	4
2024-10-21	Harris, Todd	Director,Officer	President and CEO	Direct	Sale	19,084	27.74	$529,390.16	1,355,927	4
2024-10-17	Harris, Todd	Director,Officer	President and CEO	Direct	Sale	15,394	26.10	$401,783.40	1,418,647	4
2024-09-30	Harris, Todd	Director,Officer	President and CEO	Direct	Sale	500	24.00	$12,000.00	1,477,373	4
2024-09-25	Harris, Todd	Director,Officer	President and CEO	Direct	Sale	600	24.01	$14,406.00	1,477,873	4
2024-09-20	Harris, Todd	Director,Officer	President and CEO	Direct	Sale	7,109	24.19	$171,966.71	1,489,620	4
2024-06-10	Bensen, Daniel	Officer	Chief Operating Officer	Direct	Sale	3,502	20.00	$70,040.00	427,981	4
2024-03-11	Bensen, Daniel	Officer	Chief Operating Officer	Direct	Sale	200	20.00	$4,000.00	431,683	4
2024-03-07	Bensen, Daniel	Officer	Chief Operating Officer	Direct	Sale	68	20.00	$1,360.00	431,883	4
2024-03-05	Bensen, Daniel	Officer	Chief Operating Officer	Direct	Sale	1,189	20.02	$23,803.78	433,684	4
2024-02-29	Bensen, Daniel	Officer	Chief Operating Officer	Direct	Sale	2,050	20.00	$41,000.00	442,836	4
2024-02-12	Bensen, Daniel	Officer	Chief Operating Officer	Direct	Sale	1,501	20.00	$30,020.00	451,480	4
2024-02-07	Bensen, Daniel	Officer	Chief Operating Officer	Direct	Sale	9,587	18.09	$173,428.83	452,981	4
2024-02-06	Bensen, Daniel	Officer	Chief Operating Officer	Direct	Sale	15,413	18.09	$278,821.17	462,568	4
2024-02-05	Harris, Todd	Director,Officer	President and CEO	Direct	Sale	13,817	16.97	$234,474.49	1,502,697	4
2023-07-21	Bensen, Daniel	Officer	Chief Operating Officer	Direct	Sale	3,900	16.01	$62,439.00	527,981	4
2023-07-17	Bensen, Daniel	Officer	Chief Operating Officer	Direct	Sale	1,900	16.03	$30,457.00	527,981	4
2023-07-12	Bensen, Daniel	Officer	Chief Operating Officer	Direct	Sale	201	16.23	$3,262.23	527,981	4
2023-07-03	Bensen, Daniel	Officer	Chief Operating Officer	Direct	Sale	4,265	16.67	$71,097.55	527,981	4
2023-06-28	Bensen, Daniel	Officer	Chief Operating Officer	Direct	Sale	13,524	16.91	$228,690.84	527,981	4
2023-06-23	Harris, Todd	Director,Officer	Chief Executive Officer	Direct	Sale	20,712	17.15	$355,210.80	1,601,276	4
2023-06-21	Harris, Todd	Director,Officer	Chief Executive Officer	Direct	Sale	19,756	17.34	$342,569.04	1,625,466	4
2023-06-15	Harris, Todd	Director,Officer	Chief Executive Officer	Direct	Sale	12,773	16.13	$206,028.49	1,701,276	4
2023-06-15	Bensen, Daniel	Officer	Chief Operating Officer	Direct	Sale	12,592	16.15	$203,360.80	527,981	4
2023-04-03	Harris, Todd	Director,Officer	Chief Executive Officer	Direct	Sale	2,000	16.13	$32,260.00	1,701,276	4
2023-04-03	Bensen, Daniel	Officer	Chief Operating Officer	Direct	Sale	2,000	16.16	$32,320.00	527,981	4
2023-03-31	Harris, Todd	Director,Officer	Chief Executive Officer	Direct	Sale	500	16.05	$8,025.00	1,701,276	4
2023-03-29	Bensen, Daniel	Officer	Chief Operating Officer	Direct	Sale	2,187	16.21	$35,451.27	527,981	4
2023-03-28	Harris, Todd	Director,Officer	Chief Executive Officer	Direct	Sale	2,779	16.00	$44,464.00	1,701,276	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

104.75%

Inst. Shares: 64,676,168

Shares Outstanding: 61,746,050

2025-12-31

95.02%

Inst. Shares: 56,633,061

Shares Outstanding: 59,602,328

2025-09-30

93.18%

Inst. Shares: 55,602,979

Shares Outstanding: 59,670,757

2025-06-30

94.73%

Inst. Shares: 56,410,848

Shares Outstanding: 59,550,771

2025-03-31

90.10%

Inst. Shares: 53,464,914

Shares Outstanding: 59,336,550

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	64,676,168	61,746,050	104.75%
2025-12-31	56,633,061	59,602,328	95.02%
2025-09-30	55,602,979	59,670,757	93.18%
2025-06-30	56,410,848	59,550,771	94.73%
2025-03-31	53,464,914	59,336,550	90.10%
2024-12-31	48,536,747	57,217,746	84.83%
2024-09-30	46,968,455	58,874,497	79.78%
2024-06-30	46,648,867	58,668,712	79.51%
2024-03-31	46,482,707	52,228,934	89.00%
2023-12-31	35,732,014	42,704,876	83.67%
2023-09-30	36,435,561	42,868,340	84.99%
2023-06-30	29,737,876	42,589,213	69.82%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Tyra Biosciences, Inc. (TYRA) — SEC Financial Statements & Analysis

Tyra Biosciences, Inc. (TYRA) is a pharmaceutical preparations company, incorporated in DE. Tyra Biosciences, Inc. trades on Nasdaq as: TYRA. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Tyra Biosciences, Inc. reported a Debt-to-Equity ratio of 0.08x, a Price-to-Book (P/B) ratio of 5.96x (TTM), at a market cap of $2.11B. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.08x
P/B TTM: 5.96x
Market Cap: $2.11B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Tyra Biosciences, Inc. in?

Tyra Biosciences, Inc. (TYRA) operates in the Pharmaceutical Preparations industry.

What is TYRA's market cap?

Tyra Biosciences, Inc. (TYRA) has a market capitalization of $2.11B as of 2026-06-30.

What exchange does TYRA trade on?

Tyra Biosciences, Inc. (TYRA) trades on the Nasdaq.

Where is Tyra Biosciences, Inc. incorporated?

Tyra Biosciences, Inc. is incorporated in DE.